JP2011505414A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011505414A5 JP2011505414A5 JP2010536523A JP2010536523A JP2011505414A5 JP 2011505414 A5 JP2011505414 A5 JP 2011505414A5 JP 2010536523 A JP2010536523 A JP 2010536523A JP 2010536523 A JP2010536523 A JP 2010536523A JP 2011505414 A5 JP2011505414 A5 JP 2011505414A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- composition
- subject
- item
- factor viii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0723712.6A GB0723712D0 (en) | 2007-12-04 | 2007-12-04 | Peptides |
| GB0723712.6 | 2007-12-04 | ||
| PCT/GB2008/003996 WO2009071886A1 (en) | 2007-12-04 | 2008-12-03 | Fviii peptides and their use in tolerising haemophiliacs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014023217A Division JP6063402B2 (ja) | 2007-12-04 | 2014-02-10 | Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011505414A JP2011505414A (ja) | 2011-02-24 |
| JP2011505414A5 true JP2011505414A5 (https=) | 2012-10-25 |
| JP5501245B2 JP5501245B2 (ja) | 2014-05-21 |
Family
ID=38982965
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010536523A Expired - Fee Related JP5501245B2 (ja) | 2007-12-04 | 2008-12-03 | Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用 |
| JP2014023217A Expired - Fee Related JP6063402B2 (ja) | 2007-12-04 | 2014-02-10 | Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014023217A Expired - Fee Related JP6063402B2 (ja) | 2007-12-04 | 2014-02-10 | Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8445448B2 (https=) |
| EP (1) | EP2227488B3 (https=) |
| JP (2) | JP5501245B2 (https=) |
| KR (1) | KR101519840B1 (https=) |
| CN (2) | CN101889024B (https=) |
| AU (1) | AU2008332968B2 (https=) |
| BR (1) | BRPI0820143A2 (https=) |
| CA (2) | CA3005013C (https=) |
| CY (1) | CY1115168T1 (https=) |
| DK (1) | DK2227488T6 (https=) |
| EA (1) | EA019370B1 (https=) |
| EC (1) | ECSP10010327A (https=) |
| ES (1) | ES2458315T7 (https=) |
| GB (1) | GB0723712D0 (https=) |
| HR (1) | HRP20140344T4 (https=) |
| IL (1) | IL205780A (https=) |
| MX (1) | MX2010006084A (https=) |
| MY (1) | MY150995A (https=) |
| NZ (1) | NZ585217A (https=) |
| PL (1) | PL2227488T6 (https=) |
| PT (1) | PT2227488E (https=) |
| SI (1) | SI2227488T1 (https=) |
| UA (1) | UA101003C2 (https=) |
| WO (1) | WO2009071886A1 (https=) |
| ZA (1) | ZA201002997B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1731912T1 (sl) | 2000-08-21 | 2014-05-30 | Apitope Technology (Bristol) Limited | Postopek izbire peptida |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
| KR20160104740A (ko) * | 2008-06-24 | 2016-09-05 | 옥타파마 아게 | 응고 인자 ｖｉｉｉ을 정제하는 방법 |
| GB0908515D0 (en) * | 2009-05-18 | 2009-06-24 | Apitope Technology Bristol Ltd | Peptide |
| SG176783A1 (en) * | 2009-06-16 | 2012-01-30 | Univ Tokai | Anti-gram-negative bacteria agent |
| BR112013010362A2 (pt) * | 2010-10-27 | 2016-08-02 | Baxter Healthcare Sa | métodos para induzir uma tolerância imune a fviii, para fazer um peptídeo fviii, e para identificar uma célula t específica de peptídeo fvii, peptídeo, composição, e, proteína de fusão |
| EP3970737A1 (en) | 2012-01-12 | 2022-03-23 | Bioverativ Therapeutics Inc. | Reducing immunogenicity against factor viii in individuals undergoing factor viii therapy |
| RS56069B1 (sr) * | 2012-11-12 | 2017-10-31 | Apitope Int Nv | Faktor viii-izvedenih peptida za upotrebu u lečenju hemofilije a |
| GB201314052D0 (en) * | 2013-08-06 | 2013-09-18 | Apitope Int Nv | Peptides |
| CN108884140B (zh) | 2015-12-03 | 2022-10-25 | 朱诺治疗学股份有限公司 | 修饰的嵌合受体及相关组合物和方法 |
| CN110520149A (zh) | 2016-12-02 | 2019-11-29 | 比奥维拉迪维治疗股份有限公司 | 诱导对凝血因子的免疫耐受性的方法 |
| US12077607B2 (en) * | 2021-09-23 | 2024-09-03 | University Of Utah Research Foundation | Functional and therapeutic effects of PAR4 cleavage by cathepsin G |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990015615A1 (en) | 1989-06-20 | 1990-12-27 | Scripps Clinic And Research Foundation | The phospholipid binding domain of factor viii |
| BR9806793A (pt) * | 1997-01-22 | 2000-05-16 | Univ Texas | Processos e composições de fator tissular para coagulação e tratamento de tumores. |
| SI1731912T1 (sl) * | 2000-08-21 | 2014-05-30 | Apitope Technology (Bristol) Limited | Postopek izbire peptida |
| US20040096456A1 (en) * | 2000-12-01 | 2004-05-20 | Conti-Fine Bianca M | Method to treat hemophilia |
| US7189830B2 (en) * | 2001-02-19 | 2007-03-13 | Merck Patent Gmbh | Anti-KSA/IL-2 fusion proteins with reduced immunogenicity |
| AU2002312660A1 (en) | 2001-05-31 | 2002-12-16 | D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| JP2005538694A (ja) * | 2002-04-18 | 2005-12-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 修飾されたｖｉｉｉ因子 |
| ES2567634T3 (es) * | 2004-02-09 | 2016-04-25 | Human Genome Sciences, Inc. | Proteínas de fusión de albúmina |
| WO2006003183A1 (de) | 2004-07-02 | 2006-01-12 | Alois Jungbauer | Peptide zur blockierung von fviii-inhibitoren |
| IL229645A0 (en) * | 2013-11-26 | 2014-03-31 | Omrix Biopharmaceuticals Ltd | A dry bandage containing thrombin and pectin |
-
2007
- 2007-12-04 GB GBGB0723712.6A patent/GB0723712D0/en not_active Ceased
-
2008
- 2008-03-12 UA UAA201008194A patent/UA101003C2/uk unknown
- 2008-12-03 US US12/746,141 patent/US8445448B2/en not_active Expired - Fee Related
- 2008-12-03 HR HRP20140344TT patent/HRP20140344T4/hr unknown
- 2008-12-03 DK DK08855772.3T patent/DK2227488T6/en active
- 2008-12-03 BR BRPI0820143 patent/BRPI0820143A2/pt not_active Application Discontinuation
- 2008-12-03 EA EA201070681A patent/EA019370B1/ru not_active IP Right Cessation
- 2008-12-03 EP EP08855772.3A patent/EP2227488B3/en active Active
- 2008-12-03 AU AU2008332968A patent/AU2008332968B2/en not_active Ceased
- 2008-12-03 CN CN200880119313.1A patent/CN101889024B/zh not_active Expired - Fee Related
- 2008-12-03 JP JP2010536523A patent/JP5501245B2/ja not_active Expired - Fee Related
- 2008-12-03 KR KR1020107011743A patent/KR101519840B1/ko not_active Expired - Fee Related
- 2008-12-03 PT PT88557723T patent/PT2227488E/pt unknown
- 2008-12-03 WO PCT/GB2008/003996 patent/WO2009071886A1/en not_active Ceased
- 2008-12-03 CA CA3005013A patent/CA3005013C/en active Active
- 2008-12-03 ES ES08855772.3T patent/ES2458315T7/es active Active
- 2008-12-03 CN CN201310392152.6A patent/CN103709234B/zh not_active Expired - Fee Related
- 2008-12-03 SI SI200831186T patent/SI2227488T1/sl unknown
- 2008-12-03 NZ NZ585217A patent/NZ585217A/xx not_active IP Right Cessation
- 2008-12-03 MY MYPI20102567 patent/MY150995A/en unknown
- 2008-12-03 PL PL08855772T patent/PL2227488T6/pl unknown
- 2008-12-03 CA CA2707559A patent/CA2707559C/en active Active
- 2008-12-03 MX MX2010006084A patent/MX2010006084A/es active IP Right Grant
-
2010
- 2010-04-29 ZA ZA2010/02997A patent/ZA201002997B/en unknown
- 2010-05-13 IL IL205780A patent/IL205780A/en active IP Right Grant
- 2010-07-02 EC EC2010010327A patent/ECSP10010327A/es unknown
-
2014
- 2014-02-10 JP JP2014023217A patent/JP6063402B2/ja not_active Expired - Fee Related
- 2014-04-15 CY CY20141100281T patent/CY1115168T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011505414A5 (https=) | ||
| Morató et al. | Symptomatic and disease-modifying therapy pipeline for Alzheimer’s disease: Towards a personalized polypharmacology patient-centered approach | |
| Sweeney et al. | Protein misfolding in neurodegenerative diseases: implications and strategies | |
| JP2012515778A5 (https=) | ||
| Yang et al. | The roles of noncardiomyocytes in cardiac remodeling | |
| US20170312334A1 (en) | Methods and compositions for treating inflammatory disorders | |
| Yang et al. | Heart failure: advanced development in genetics and epigenetics | |
| Stone et al. | Genomics of human fibrotic diseases: disordered wound healing response | |
| CN112661838A (zh) | 用于肺癌(包括非小细胞肺癌和其他癌症)免疫治疗的新型肽和肽组合物 | |
| JP2017525336A5 (https=) | ||
| JP2014533102A5 (https=) | ||
| JP2015504299A5 (https=) | ||
| JP2009540852A5 (https=) | ||
| JP2015522264A5 (https=) | ||
| Nielsen et al. | Toward personalized lymphoma immunotherapy: identification of common driver mutations recognized by patient CD8+ T cells | |
| Kjer-Hansen et al. | Protein isoform-centric therapeutics: expanding targets and increasing specificity | |
| JP2019500057A (ja) | ネオエピトープのウイルス送達のための改善された組成物および方法ならびにその使用 | |
| JP2012527440A5 (https=) | ||
| FI20011664A7 (fi) | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö | |
| Chattopadhyay et al. | Preventing cholesterol-induced perk (protein kinase RNA-like endoplasmic reticulum kinase) signaling in smooth muscle cells blocks atherosclerotic plaque formation | |
| Turcot et al. | Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome | |
| MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. | |
| JP2010526090A5 (https=) | ||
| Duan et al. | Calcitonin gene-related peptide improves hypoxia-induced inflammation and apoptosis via nitric oxide in H9c2 cardiomyoblast cells | |
| Hassan et al. | Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights |